Atlas Trials

A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT07747155 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07747155
Sponsor
Pyrotech Therapeutics, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis (UC)
Start date
2026-08-01
Primary completion
2027-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.